Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v9-FR | Version v1-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2025-01-23 | 2024-08-13 |
| Drug Identification Number | 02492768 | 02492768 |
| Brand name | ARSENIC TRIOXIDE FOR INJECTION | ARSENIC TRIOXIDE FOR INJECTION |
| Common or Proper name | ARSENIC TRIOXIDE FOR INJECTION | ARSENIC TRIOXIDE FOR INJECTION |
| Company Name | STERIMAX INC | STERIMAX INC |
| Ingredients | ARSENIC TRIOXIDE | ARSENIC TRIOXIDE |
| Strength(s) | 1MG | 1MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging sizes (GTIN) | (See additional packaging sizes) | (See additional packaging sizes) |
| Additional packaging sizes | PACK OF 10 VIALS | PACK OF 10 VIALS |
| ATC code | L01XX | L01XX |
| ATC description | OTHER ANTINEOPLASTIC AGENTS | OTHER ANTINEOPLASTIC AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. | Delay in shipping of the drug. |
| Anticipated start date | 2024-08-31 | 2024-08-31 |
| Actual start date | ||
| Estimated end date | 2025-09-05 | Unknown |
| Actual end date | ||
| Shortage status | Actual shortage | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Remaining inventory is short-dated expiring August 31, 2024. | |
| Health Canada comments |